# External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

> **NCT01603420** · PHASE2,PHASE3 · TERMINATED · sponsor: **Proton Collaborative Group** · enrollment: 2 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Luteinizing hormone-releasing hormone (LHRH)
- **DRUG:** Docetaxel
- **OTHER:** Conformal Radiation Therapy (RT)

## Key facts

- **NCT ID:** NCT01603420
- **Lead sponsor:** Proton Collaborative Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** enrollment goals not met
- **Last updated:** 2016-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01603420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01603420, "External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01603420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*